170 related articles for article (PubMed ID: 28143602)
1. Rubella in Sub-Saharan Africa and sensorineural hearing loss: a case control study.
Caroça C; Vicente V; Campelo P; Chasqueira M; Caria H; Silva S; Paixão P; Paço J
BMC Public Health; 2017 Feb; 17(1):146. PubMed ID: 28143602
[TBL] [Abstract][Full Text] [Related]
2. Sero-prevalence of rubella among pregnant women in Sub-Saharan Africa: a meta-analysis.
Kassa ZY; Hussen S; Asnake S
Hum Vaccin Immunother; 2020 Oct; 16(10):2472-2478. PubMed ID: 32195620
[No Abstract] [Full Text] [Related]
3. Modelling the incidence of congenital rubella syndrome in developing countries.
Cutts FT; Vynnycky E
Int J Epidemiol; 1999 Dec; 28(6):1176-84. PubMed ID: 10661666
[TBL] [Abstract][Full Text] [Related]
4. Genetic Basis of Nonsyndromic Sensorineural Hearing Loss in the Sub-Saharan African Island Population of São Tomé and Príncipe: The Role of the DFNB1 Locus?
Caroça C; de Matos TM; Ribeiro D; Lourenço V; Martins T; Campelo P; Fialho G; Silva SN; Paço J; Caria H
OMICS; 2016 Aug; 20(8):449-55. PubMed ID: 27501294
[TBL] [Abstract][Full Text] [Related]
5. Progress Toward Rubella and Congenital Rubella Syndrome Control - South-East Asia Region, 2000-2016.
Khanal S; Bahl S; Sharifuzzaman M; Dhongde D; Pattamadilok S; Reef S; Morales M; Dabbagh A; Kretsinger K; Patel M
MMWR Morb Mortal Wkly Rep; 2018 Jun; 67(21):602-606. PubMed ID: 29851943
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.
Hachiya M; Miyano S; Mori Y; Vynnycky E; Keungsaneth P; Vongphrachanh P; Xeuatvongsa A; Sisouk T; Som-Oulay V; Khamphaphongphane B; Sengkeopaseuth B; Pathammavong C; Phounphenghak K; Kitamura T; Takeda M; Komase K
PLoS One; 2018; 13(3):e0194931. PubMed ID: 29596472
[TBL] [Abstract][Full Text] [Related]
7. Rubella sero-prevalence among children in Kilimanjaro region: a community based study prior to the introduction of rubella vaccine in Tanzania.
Chotta NAS; Mgongo M; Uriyo JG; Msuya SE; Stray-Pedersen B; Stray-Pedersen A
Ital J Pediatr; 2017 Jul; 43(1):63. PubMed ID: 28732540
[TBL] [Abstract][Full Text] [Related]
8. Congenital hearing impairment associated with rubella: lessons from Bangladesh.
Rahman MM; Khan AM; Hafiz MM; Ronny FM; Ara S; Chowdhury SK; Nazir SS; Khan WI
Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):811-7. PubMed ID: 12757231
[TBL] [Abstract][Full Text] [Related]
9. Targeting rubella for elimination.
Taneja DK; Sharma P
Indian J Public Health; 2012; 56(4):269-72. PubMed ID: 23354136
[TBL] [Abstract][Full Text] [Related]
10. Informing rubella vaccination strategies in East Java, Indonesia through transmission modelling.
Wu Y; Wood J; Khandaker G; Waddington C; Snelling T
Vaccine; 2016 Nov; 34(46):5636-5642. PubMed ID: 27670077
[TBL] [Abstract][Full Text] [Related]
11. Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: Potential impact on vaccination policy.
Alleman MM; Wannemuehler KA; Hao L; Perelygina L; Icenogle JP; Vynnycky E; Fwamba F; Edidi S; Mulumba A; Sidibe K; Reef SE
Vaccine; 2016 Dec; 34(51):6502-6511. PubMed ID: 27866768
[TBL] [Abstract][Full Text] [Related]
12. Rubella control in Papua New Guinea: age-specific immunity informs strategies for introduction of rubella vaccine.
Riddell M; Senn N; Clements CJ; Hobday L; Cowie B; Kurubi J; Kevin A; Siba P; Reeder JC; Morgan C
Vaccine; 2012 Dec; 30(52):7506-12. PubMed ID: 23103194
[TBL] [Abstract][Full Text] [Related]
13. Congenital rubella syndrome in Iran.
Sadighi J; Eftekhar H; Mohammad K
BMC Infect Dis; 2005 Jun; 5():44. PubMed ID: 15938744
[TBL] [Abstract][Full Text] [Related]
14. Serological evidence of acute rubella infection among under-fives in Mwanza: a threat to increasing rates of congenital rubella syndrome in Tanzania.
Mirambo MM; Aboud S; Mushi MF; Seugendo M; Majigo M; Groß U; Mshana SE
Ital J Pediatr; 2016 May; 42(1):54. PubMed ID: 27225802
[TBL] [Abstract][Full Text] [Related]
15. Developing rubella vaccination policy in Nepal--results from rubella surveillance and seroprevalence and congenital rubella syndrome studies.
Upreti SR; Thapa K; Pradhan YV; Shakya G; Sapkota YD; Anand A; Taylor T; Mach O; Reef S; Pattamadilok S; Liyanage J; O'Connor P; Sedai T; Bhandary SR; Partridge J; Schluter W
J Infect Dis; 2011 Jul; 204 Suppl 1():S433-8. PubMed ID: 21666196
[TBL] [Abstract][Full Text] [Related]
16. Rubella seroprevalence among women of childbearing age residing in a rural region: is there a need for rubella vaccination in Turkey?
Aksakal FN; Maral I; Cirak MY; Aygun R
Jpn J Infect Dis; 2007 Jul; 60(4):157-60. PubMed ID: 17642522
[TBL] [Abstract][Full Text] [Related]
17. An epidemiological assessment towards elimination of rubella and congenital rubella syndrome in Singapore.
Chua YX; Ang LW; Low C; James L; Cutter JL; Goh KT
Vaccine; 2015 Jun; 33(27):3150-7. PubMed ID: 25887085
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India.
Sharma HJ; Padbidri VS; Kapre SV; Jadhav SS; Dhere RM; Parekh SS; Dudhane AD; Shewale SD; Namjoshi GS
J Infect Dev Ctries; 2011 Dec; 5(12):874-81. PubMed ID: 22169787
[TBL] [Abstract][Full Text] [Related]
19. [Rubella seroprevalence in Tunisian childbearing women two years after vaccination program introduction].
Chaabouni M; Messadi F; Fki L; M Z; Hammami A; Karray H
Pathol Biol (Paris); 2012 Jun; 60(3):170-3. PubMed ID: 22578467
[TBL] [Abstract][Full Text] [Related]
20. Serological makers of rubella infection in Africa in the pre vaccination era: a systematic review.
Mirambo MM; Majigo M; Aboud S; Groß U; Mshana SE
BMC Res Notes; 2015 Nov; 8():716. PubMed ID: 26602892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
